Effects of PCSK9 Inhibition With Alirocumab on Lipoprotein Metabolism in Healthy Humans.

Author: Reyes-Soffer, Gissette MD; Pavlyha, Marianna BS; Ngai, Colleen BS; Thomas, Tiffany PhD; Holleran, Stephen BS; Ramakrishnan, Rajasekhar EngScD; Karmally, Wahida DrPH, RD, CDE, CLS; Nandakumar, Renu PhD; Fontanez, Nelson BS; Obunike, Joseph PhD; Marcovina, Santica M. PhD, DSc; Lichtenstein, Alice H. DSc; Matthan, Nirupa R. PhD; Matta, James; Maroccia, Magali MSc; Becue, Frederic BSc; Poitiers, Franck MSc; Swanson, Brian PhD; Cowan, Lisa MS; Sasiela, William J. PhD; Surks, Howard K. MD; Ginsberg, Henry N. MD

Page: 352-362

http://ift.tt/2jW9a2u